Table 1.
Patient characteristics for training and testing set.
| Training Set (n = 33) | Testing Set (n = 31) | Total Set (n = 64) | P-Value | |
|---|---|---|---|---|
| Demographics | ||||
| Age (years) | 54.7 ± 9.5 | 55.3 ± 8.1 | 55.0 ± 8.8 | 0.800 |
| Sex (male) | 66.7% | 61.3% | 64.1% | 0.851 |
| Weight (kg) | 64.7 ± 13.7 | 70.2 ± 13.3 | 67.4 ± 13.7 | 0.111 |
| Body mass index (kg/m2) | 23.5 ± 4.0 | 25.7 ± 5.2 | 24.5 ± 4.7 | 0.056 |
| MELD score | 12 (8–15) | 17 (10–21) | 14 (9–21) | 0.333 |
| CTP score | 7 (6–8) | 9 (6–10.5) | 7 (6–9.3) | 0.239 |
| grade A | 42.4% | 29.0% | 35.9% | 0.392 |
| grade B | 36.4% | 38.7% | 37.5% | 1.000 |
| grade C | 21.2% | 32.3% | 26.6% | 0.474 |
| Causes for liver transplantation | ||||
| Hepatitis B virus related liver cirrhosis | 54.5% | 38.7% | 46.9% | 0.309 |
| Hepatitis C virus related liver cirrhosis | 0% | 16.1% | 7.8% | 0.053 |
| Alcoholic liver cirrhosis | 24.2% | 25.8% | 25.0% | 1.000 |
| Hepatocellular carcinoma | 54.5% | 45.2% | 50.0% | 0.617 |
| Others | 15.2% | 12.9% | 14.1% | 1.000 |
| Operation type | ||||
| Living donor | 87.9% | 90.3% | 89.1% | 1.000 |
| Deceased donor | 12.1% | 9.7% | 10.9% | 1.000 |
| Underlying disease | ||||
| Diabetes mellitus | 24.2% | 22.6% | 23.4% | 1.000 |
| Hypertension | 24.2% | 22.6% | 23.4% | 1.000 |
| Medication | ||||
| Beta blocker | 21.2% | 25.8% | 23.4% | 0.890 |
| Diuretics | 42.4% | 48.4% | 45.3% | 0.820 |
Values are expressed as mean ± standard deviation, median (interquartile range), or percent. MELD, model for end-stage liver disease; CTP, Child-Turcotte-Pugh.